No significant association was noted between HIF-1α expression levels assessed using all four cut-offs and the clinicopathological parameters, namely age, gender, cTNM stage, nodal involvement, tumor site, and Broder’s histological grade. The gene discussed is HIF1A; the disease is neoplasm.